STEM -- StemCells, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc.

STEM 18.49

+6.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (639)	6/2/2002 8:47:20 PM
From: John Soileau	Read Replies (1) of 805

What about this development? unisci.com "This finding suggests that activation of MMP-9 may be essential for renewal of blood stem cells. Drs. Heissig and Hattori from Dr. Rafii's group and colleagues from UCSF went on to demonstrate that activated MMP-9 promotes the release of a molecule called Kit-ligand (sKitL). Activated sKitL increases the mobility of stem cells from the bone marrow niche, thereby moving them to a permissive environment that is conducive to expansion and mobilization to the peripheral blood. " Does this facilitate STEM, or facilitate competition with STEM? John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next